{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:25:22Z","timestamp":1791141922431,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":1888,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1074\/jbc.m115.637124","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T02:10:58Z","timestamp":1432174258000},"page":"17020-17028","update-policy":"https:\/\/doi.org\/10.1074\/jbc.f110.005975","source":"Crossref","is-referenced-by-count":40,"title":["Identification of a Compound That Disrupts Binding of Amyloid-\u03b2 to the Prion Protein Using a Novel Fluorescence-based Assay"],"prefix":"10.1016","volume":"290","author":[{"given":"Emmanuel","family":"Risse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Badoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Farrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.637124_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/2151043a0","article-title":"Self replication and scrapie","volume":"215","author":"Griffith","year":"1967","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1074\/jbc.M115.637124_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib5","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1038\/ncomms5347","article-title":"Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked","volume":"5","author":"Sandberg","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.M115.637124_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","article-title":"A general model of prion strains and their pathogenicity","volume":"318","author":"Collinge","year":"2007","journal-title":"Science"},{"key":"10.1074\/jbc.M115.637124_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\u03b2 oligomers","volume":"457","author":"Laur\u00e9n","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"Mallucci","year":"2003","journal-title":"Science"},{"key":"10.1074\/jbc.M115.637124_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","article-title":"Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice","volume":"53","author":"Mallucci","year":"2007","journal-title":"Neuron"},{"key":"10.1074\/jbc.M115.637124_bib11","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1073\/pnas.151242598","article-title":"Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody","volume":"98","author":"Enari","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/11507","article-title":"Structural mobility of the human prion protein probed by backbone hydrogen exchange","volume":"6","author":"Hosszu","year":"1999","journal-title":"Nat. Struct. Biol"},{"key":"10.1074\/jbc.M115.637124_bib14","doi-asserted-by":"crossref","first-page":"17610","DOI":"10.1073\/pnas.1009062107","article-title":"Pharmacological chaperone for the structured domain of human prion protein","volume":"107","author":"Nicoll","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib15","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1523\/JNEUROSCI.6500-10.2011","article-title":"Alzheimer's disease brain-derived amyloid-\u03b2-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein","volume":"31","author":"Barry","year":"2011","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2202-11-130","article-title":"Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse","volume":"11","author":"Chung","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ncomms1341","article-title":"Interaction between prion protein and toxic amyloid-\u03b2 assemblies can be therapeutically targeted at multiple sites","volume":"2","author":"Freir","year":"2011","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.M115.637124_bib18","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/ncomms4374","article-title":"mGlu5 receptors and cellular prion protein mediate amyloid-\u03b2-facilitated synaptic long-term depression in vivo","volume":"5","author":"Hu","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.M115.637124_bib19","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1523\/JNEUROSCI.3526-13.2014","article-title":"Peripheral administration of a humanized anti-PrP antibody blocks Alzheimer's disease A\u03b2 synaptotoxicity","volume":"34","author":"Klyubin","year":"2014","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib20","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","article-title":"Memory impairment in transgenic Alzheimer mice requires cellular prion protein","volume":"30","author":"Gimbel","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib21","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/ncomms3416","article-title":"Amyloid-\u03b2 nanotubes are associated with prion protein-dependent synaptotoxicity","volume":"4","author":"Nicoll","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.M115.637124_bib22","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-\u03b2 oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib23","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1038\/nature09217","article-title":"The prion protein as a receptor for amyloid-\u03b2","volume":"466","author":"Kessels","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/emmm.201000082","article-title":"Prion protein and A\u03b2-related synaptic toxicity impairment","volume":"2","author":"Calella","year":"2010","journal-title":"EMBO Mol. Med"},{"key":"10.1074\/jbc.M115.637124_bib25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib26","doi-asserted-by":"crossref","first-page":"33489","DOI":"10.1074\/jbc.M111.278556","article-title":"Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein","volume":"286","author":"Griffiths","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.637124_bib27","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","article-title":"The complex PrPc-Fyn couples human oligomeric A\u03b2 with pathological Tau changes in Alzheimer's disease","volume":"32","author":"Larson","year":"2012","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib28","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","article-title":"An N-terminal fragment of the prion protein binds to amyloid-\u03b2 oligomers and inhibits their neurotoxicity in vivo","volume":"288","author":"Fluharty","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.637124_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer A\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.1074\/jbc.M115.637124_bib30","doi-asserted-by":"crossref","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","article-title":"Interaction between human prion protein and amyloid-\u03b2 (A\u03b2) oligomers: role of N-terminal residues","volume":"285","author":"Chen","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.637124_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/JAD-130950","article-title":"Cellular prion protein as a therapeutic target in Alzheimer's disease","volume":"38","author":"Laur\u00e9n","year":"2014","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.M115.637124_bib32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1242077","article-title":"Human LilrB2 is a \u03b2-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model","volume":"341","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M115.637124_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature09635","article-title":"Reversing EphB2 depletion rescues cognitive functions in Alzheimer model","volume":"469","author":"Ciss\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.637124_bib34","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI66827","article-title":"Fc\u03b3RIIb mediates amyloid-\u03b2 neurotoxicity and memory impairment in Alzheimer's disease","volume":"123","author":"Kam","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M115.637124_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1871526510909010048","article-title":"Preventing prion pathogenicity by targeting the cellular prion protein","volume":"9","author":"Nicoll","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1074\/jbc.M115.637124_bib36","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"10.1074\/jbc.M115.637124_bib37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1074\/jbc.M115.637124_bib38","doi-asserted-by":"crossref","first-page":"E4160","DOI":"10.1073\/pnas.1317164110","article-title":"Drug resistance confounding prion therapeutics","volume":"110","author":"Berry","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4838(99)00038-2","article-title":"Multiple folding pathways for heterologously expressed human prion protein","volume":"1431","author":"Jackson","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M115.637124_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(97)01330-6","article-title":"Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding","volume":"417","author":"Zahn","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.M115.637124_bib41","doi-asserted-by":"crossref","first-page":"11666","DOI":"10.1073\/pnas.1834432100","article-title":"A quantitative highly sensitive cell-based infectivity assay for mouse scrapie prions","volume":"100","author":"Kl\u00f6hn","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.97.1.145","article-title":"NMR solution structure of the human prion protein","volume":"97","author":"Zahn","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib43","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1073\/pnas.0809170106","article-title":"Crystal structure of human prion protein bound to a therapeutic antibody","volume":"106","author":"Antonyuk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.637124_bib44","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bbapap.2007.08.028","article-title":"\u03b2-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91\u2013110 that recognise native PrPSc","volume":"1774","author":"Khalili-Shirazi","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M115.637124_bib45","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1228541","article-title":"Preventing Alzheimer's disease","volume":"337","author":"Selkoe","year":"2012","journal-title":"Science"},{"key":"10.1074\/jbc.M115.637124_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci"},{"key":"10.1074\/jbc.M115.637124_bib47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"New Engl. J. Med"},{"key":"10.1074\/jbc.M115.637124_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1471-4159.1995.65010096.x","article-title":"Uptake of l-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter","volume":"65","author":"Roseth","year":"1995","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M115.637124_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bcp.2014.07.033","article-title":"Identification and characterization of human Rad51 inhibitors by screening of an existing drug library","volume":"91","author":"Normand","year":"2014","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M115.637124_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.1215579","article-title":"PrP antibodies do not trigger mouse hippocampal neuron apoptosis","volume":"335","author":"Kl\u00f6hn","year":"2012","journal-title":"Science"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820402546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820402546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.637124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T10:27:48Z","timestamp":1641292068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820402546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":50,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0021925820402546"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.637124","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}